Skip to main content
Family Practice logoLink to Family Practice
. 2012 Aug 21;30(1):25–30. doi: 10.1093/fampra/cms044

The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care

Claire Burton a, Paul Campbell a,*, Kelvin Jordan a, Vicky Strauss a, Christian Mallen a
PMCID: PMC3552314  PMID: 22915794

Abstract

Background.

Depression is identified as a risk factor for dementia. Little research has been carried out on the importance of anxiety, despite strong evidence of co-morbidity with depression.

Objective.

To examine the association of anxiety and depression with future dementia diagnosis.

Methods.

This case-control study was set in the Consultations in Primary Care Archive. Cases (n = 400), were patients aged >65 years old. About 1353 controls were matched to cases by gender, practice, age group and year of case diagnosis. Read codes of risk factors for dementia were searched in patient records. The associations of prior consultations for anxiety and depression, with future diagnosis of dementia were determined using multivariable logistic regression.

Results.

A past anxiety diagnosis was associated with a future dementia diagnosis [odds ratio 2.76 (95% confidence interval 2.11–3.62)]. The association of depression with dementia was attenuated by the high prevalence of anxiety within those who have depression. Including an interaction of depression and anxiety showed that having only depression was associated with future dementia diagnosis but a diagnosis of depression alongside anxiety did not increase the likelihood of a dementia diagnosis compared to having just an anxiety diagnosis.

Conclusion.

Prior diagnosis of anxiety was strongly associated with dementia diagnosis after adjustment for other risk factors. The independent effect of depression was weaker compared to anxiety. Given the higher prevalence of anxiety primary care physicians should consider anxiety as well as depression as premorbid risk factors of dementia to improve early recognition and facilitate greater access to services.

Keywords. Anxiety, dementia, depression, epidemiology, primary care.

Introduction

The term ‘dementia’ describes a ‘collection of symptoms including a decline in memory, reasoning and communication skills and a gradual loss of skills needed to carry out every day living.1 Approximately 700 000 people in the UK suffer from dementia, costing the economy £17 billion a year.1 Over the next 30 years the number of people with dementia is forecast to double, with costs trebling to over £50 billion a year.2 The rate of diagnosis of dementia is low and variable in the UK.3 Estimations suggest that only one-third of people with dementia receive a formal diagnosis leading to a lower level of access to management interventions such as medication and social support that could improve outcome.1,4 As there is no known cure for dementia the aim of current clinical management is to reduce the risk of developing dementia and minimise its consequences. This principle underpins the National Dementia Strategy’s public health campaign.3

Many risk factors have been identified in the literature.5 One strong risk factor is premorbid depression. Prospective studies show an increase in risk for dementia if the person has or reports they have depression.6–8 However, contradictory evidence exists on whether the relationship between depression and later dementia is similar in men and women. The PAQUID study found a positive association between dementia and depression in men only.9 The CHSA (Community Health Status Assessment) however found that depression increased the risk of vascular dementia in both sexes.10 Less is known about the role of premorbid anxiety despite evidence of close co-morbidity with depression and evidence that anxiety may be a predisposing factor for depression.11,12 One recent prospective cohort study (Gallacher et al.13) reported that after adjustment for age, vascular risk factors and premorbid cognitive function, higher anxiety levels were significantly associated with cognitive impairment and non-vascular dementia in a male population. However they did not adjust for possible co-morbid depression and comment that further study is required to distinguish whether the association between anxiety and dementia is independent of the relationship between depression and dementia.

This study aimed to examine relative associations of a prior anxiety diagnosis, or a prior depression diagnosis, with future diagnosis of dementia in primary care. Recognition of predisposing factors for dementia should alert primary care physicians to the increased risk of dementia, in order to facilitate the early recognition and management of this disease.

Methods

Setting

The setting for this study is the Consultations in Primary Care Archive (CiPCA). CiPCA is a high quality, validated database, containing recorded consultation data from 13 general practices in North Staffordshire, UK from 1998. Ethical approval for the use of CiPCA was granted by the North Staffordshire Research Ethics Committee.14,15 CiPCA contains information on all primary care consultations with these practices. CiPCA practices utilise Read codes to record consultation data, a common method in UK primary care. Read codes are used to record categories of symptoms and diagnoses. They make up a hierarchical ‘thesaurus’ stored by the computer. Clinical information is stored as data which is retrievable and analysable.16

Participants

Cases and controls were identified from the 10 practices which contributed consultation data to CiPCA for the entire study period (2000 to 2008). In 2008, the 10 practices had a registered population of 96 618 patients. Dementia cases were identified by a Read coded (codes available on request) primary care consultation (or documentation from specialist services) in the period 2003–08, with no prior Read code for dementia, from 2000 onwards and were aged 65 years or more at time of first diagnosis. Patients had to be fully registered at least 3 years prior to the date of dementia diagnosis and have consulted a primary care physician in the year preceding their diagnosis. This timeframe was chosen to allow for a 3-year run-in period (2000 to 2003) to ensure that only people with a newly coded diagnosis of dementia were included. Research has shown that patients may wait up to 3 years before consulting a primary care physician after their initial symptoms appear.3

Exclusion criteria for cases

The lower age limit of 65 years was chosen to coincide with the International Classification of Disease Version—10 definition of late-onset dementia. Patients with diagnostic Read codes of dementia subtypes including Lewy Body dementia, frontotemporal dementia and HIV associated dementia were also excluded as they have potentially different aetiologies.

Controls

Patients in the control group were randomly selected via The Statistical Package for Social Sciences (random number generation command, version 20, SPSS Inc., Chicago, IL). A ratio of between three and four controls to one case were frequency matched by age group at diagnosis, gender, practice and consultation in the same year as the case’s first dementia diagnosis. The controls had no dementia diagnosis for the entire time period 2000–08, had to have registration at the practice for at least 3 years prior to the year of diagnosis of their matched case and had a recorded consultation in the year of diagnosis of the matched case. Matching factors were age and gender, due to the differences in the risk factors for dementia by gender and the rising incidence of dementia associated with age, and GP practice, due to possible differences between practices in socio-economic status and diagnosis or recording practice.

Risk factors

A review of the literature on risk factors for dementia was completed by the first author (CB). Two practicing primary care physicians (first author and last author) independently reviewed the risk factors to identify those factors accessible within routinely collected primary care records. The two reviewers then discussed the inclusion of the risk factors at a final consensus meeting. Read codes for each risk factor (available on request) were identified using the UKTC (UK Terminology centre) Clinical Terminology Browser. The Database of Raw Read codes was also hand searched for relevant Read codes to ensure that categories of codes were not missed. The risk factors identified using the above methods were alcohol misuse,17–19 smoking,20 obesity,21,22 hypertension,23 ischemic heart disease,8 cerebrovascular disease,24,25 hypotension,5,26 dyslipidaemia,27 diabetes,8,2830 anxiety13 and depression.7,911 The ‘lifestyle’ variables including alcohol misuse, smoking and obesity were found to be poorly coded (e.g. only 4 people had a Read code for smoking) and were not included in further analyses. Risk factor information was extracted from the primary care records for each case and control from 1 January 2000 up to the date of diagnosis for the cases.

Analyses

Unconditional logistic regression was used to assess both the unadjusted and adjusted association of each risk factor with dementia after controlling for the matched criteria, with odds ratios and 95% confidence intervals reported. All risk factor variables were then entered in the fully adjusted analysis. Finally an interaction term of anxiety with depression was included in the adjusted model due to evidence that anxiety and depression often coexist clinically.11,12 Multivariable analyses were also stratified by gender to assess whether any association between anxiety and depression with dementia was consistent between genders. The analyses were conducted using SPSS version 20.

Results

Four hundred cases of patients with a new dementia diagnosis were identified with 1353 controls. All cases were frequency matched with at least three controls (mean number of controls per case was 3.38); this number varied due to differences in number of eligible controls between practices particularly for the 92+ year group. The mean ages were 80.87 (SD 6.19) for controls and 81.40 (SD 6.5) for cases, 63% of the controls and 62% of the cases were female.

One hundred and twenty two (31%) of cases had a prior diagnosis of anxiety compared to 14% of controls. Prior diagnosis of depression was also higher in some cases (10% versus 5%). Half of those with a depression diagnosis also had a recorded diagnosis of anxiety. Unadjusted analysis showed the presence of a prior Read code for anxiety [OR 2.76 (95% CI 2.11–3.62)], depression [OR 2.19 (95% CI 1.44–3.31)] and cerebrovascular disease [OR 1.97 (95% CI 1.42–2.73)] and increased the odds of a later dementia diagnosis. An anxiety diagnosis remained significantly associated with future dementia [OR 2.67 (95% CI 2.01–3.54)] after adjustment, but depression was not significantly associated [OR1.54 (95% CI 0.99–2.39)], (Table 1). However examination of the interaction analysis showed that having a depression diagnosis alone was significantly associated with dementia [OR 2.54 (95% CI 1.39–4.63)] compared to those with neither anxiety or depression but that this association was less strong than the effect of having depression with anxiety [OR 2.85 (95% CI 1.60–5.07)] or having only anxiety [OR 2.97 (95% CI 2.21–4.00)], (Table 2).

Table 1.

Unadjusted and adjusted associations of risk factors with future diagnosis of dementia

Risk factor Cases with risk factor present n (%) Controls with risk factor present n (%) Odds ratio (95% confidence interval)* Multivariable analysis. Odds ratio (95% CI)a
Anxiety 122 (30.5) 192 (14.2) 2.76 (2.11–3.62) 2.67 (2.01–3.54)
Depression 41 (10.3) 67 (5.0) 2.19 (1.44–3.31) 1.54 (0.99–2.39)
Cerebrovascular Disease 66 (16.5) 127 (9.4) 1.97 (1.42–2.73) 2.18 (1.55–3.07)
Diabetes 51 (12.8) 162 (12.0) 1.08 (0.77–1.52) 1.20 (0.84–1.71)
Dyslipidaemia 43 (10.8) 200 (14.8) 0.69 (0.48–0.99) 0.68 (0.46–0.99)
Hypertension 174 (43.5) 720 (53.2) 0.68 (0.54–0.85) 0.69 (0.54–0.87)
Hypotension 10 (2.5) 31 (2.3) 1.04 (0.50–2.17) 0.87 (0.40–1.88)
Ischemic heart Disease 68 (17) 249 (18.4) 0.93 (0.69–1.26) 0.89 (0.65–1.22)

*Controlling for age, gender, practice and year of case diagnosis of dementia.

aControlling for all variables presented.

Table 2.

Association of having diagnosis of both depression and anxiety on future diagnosis of dementia

Risk factor Case n (%) Control n (%) Multivariable analysis. Odds ratio (95% CI)a
No anxiety or depression 258 (64.4) 1129 (93.4) 1.00
Anxiety alone 101 (25.3) 157 (11.6) 2.97 (2.21–4.00)
Depression alone 20 (5.0) 32 (2.4) 2.54 (1.39–4.63)
Anxiety and depression 21 (5.3) 35 (2.6) 2.85 (1.60–5.07)

aMultivariable model controlling for age, gender, practice, year of case diagnosis of dementia and all risk factors and including interaction of anxiety with depression.

Of the other risk factors, a previous diagnosis of cerebrovascular disease [OR 2.18 (95% CI 1.55–3.07)] increased the odds of dementia but a previous diagnosis of hypertension or dyslipidaemia decreased the odds of dementia [adjusted OR 0.69 (95% CI 0.54–0.87)] and [adjusted OR 0.68 (95% CI 0.46–0.99)] respectively.

Stratification by gender (Table 3) indicated that the association of depression only with dementia was higher in males than females. There was less of a difference between genders on the association of anxiety only and both depression and anxiety with future dementia.

Table 3.

Association of depression and anxiety with diagnosis of dementia by gender

Risk factor Case n (%) Control n (%) Multivariable analysis. Odds ratio (95% CI)a
Female
No anxiety or depression 152 (60.6) 666 (79.9) 1
Anxiety alone 73 (29.1) 115 (13.8) 1.71 (0.79–3.70)
Depression alone 11 (4.4) 26 (3.1) 2.95 (2.07–4.22)
Anxiety and depression 15 (6.0) 27 (3.2) 2.65 (1.35–5.23)
Male
No anxiety or depression 106 (71.1) 463 (89.2) 1
Anxiety alone 28 (18.8) 42 (8.1) 3.12 (1.78–5.47)
Depression alone 9 (6.0) 6 (1.2) 5.91 (1.98–17.6)
Anxiety and depression 6 (4.0) 8 (1.5) 3.90 (1.21–12.57)

aMultivariable model controlling for age, gender, practice, year of case diagnosis of dementia, and all risk factors and including interaction of anxiety with depression.

Discussion

This study considered the association of diagnoses of anxiety and depression with the future outcome of a dementia diagnosis. A history of anxiety independently increased the odds of being diagnosed with dementia in a primary care setting. Having depression without anxiety was also significantly associated with being diagnosed with dementia, however, having a diagnosis of depression alongside anxiety did not increase the likelihood of a dementia diagnosis compared to having just an anxiety diagnosis.

Interpretation

Anxiety was independently associated with a future dementia diagnosis and was more prevalent within the cohort compared to depression. Half of those with depression also had anxiety diagnoses. This is suggestive that anxiety represents a more important risk factor for dementia than had been previously thought, and along with depression represents an affective risk component that could be screened for within primary care.

One potential explanatory factor is that anxiety was being diagnosed by primary care physicians in patients experiencing mild cognitive impairment (MCI), preceding a later diagnosis of dementia. This concurs with previous work, which suggested that anxiety in patients with MCI does strongly predispose to progression to a dementia diagnosis.31 Gallacher et al. also showed that high trait anxiety was an independent risk factor for developing cognitive impairment and non-vascular dementia.13 In contrast a study by Bierman et al., did not find a long-term effect for cognitive decline in patients with anxiety.32 They measured self-reported symptoms of anxiety using HADS-A (The Hospital Anxiety and Depression Scale—Anxiety). However their analysis used the scale score of the HADS-A which may not be reflective of the clinically relevant levels of anxiety that may incur a Read code from a primary care physician.

One physiological explanation why chronic anxiety may contribute to cognitive decline is Sapolsky’s glucocorticoid cascade hypothesis. This hypothesis suggests that high levels of glucocorticoids, brought about by prolonged stress from anxiety and depression, can lead to neurotoxicity and atrophy within the hippocampus which is associated with memory processes.33 It seems clinically reasonable to postulate that, in a similar way to depression, patients may experience and present with anxiety symptoms as a direct cause of the insight they have into their early experiences of MCI. Gallacher et al. however felt that the long run-in period of their study meant that their results were unlikely to be explained by this hypothesis and prefer an explanation including a common biological pathway linking anxiety, depression and dementia (possibly serotonergic).13

This study demonstrated differences in the association of dementia and depression between male and females. Prevalence of depression in the male control group was lower than in the female controls. Lower consultation rates and later presentation of depression in men may be a confounding factor, as the severity of depression in females and males may differ. A male patient presenting with depression may therefore be a ‘red flag’ when considering a possible diagnosis of dementia. ‘Vascular depression’ has been postulated as an accelerant of dementia and cardiovascular disease being more common in men may explain this study’s finding. As depression in women is more common and the cause of their depression more heterogeneous, such an association in this group would be masked.9 Cerebrovascular disease was a significant risk factor for dementia as would be expected from previous studies.24,25 Hypertension and dyslipidaemia appeared to decrease the odds for developing dementia, an unexpected result although the results were close to non-significance. It is likely that the patients identified had controlled disease (unlike in population studies) and were on medication that may represent a confounding factor.34–38 As expected, ischemic heart disease was not a significant risk factor.8 The results for diabetes (a well recognised independent risk factor)8,30 were also unexpectedly non-significant.

Strengths and limitations

By setting the study in the consulting primary care population, using routinely recorded data, the findings are applicable to the primary care population. The sample size was large however, it did not include patients who do not use primary care services. This study is based on anxiety and depression presented by patients rather than self-reported. It is possible that some diagnoses were not coded or mis-coded, although the quality control measures in place around the database should decrease this risk. Due to the nature of the Read code system and the anonymised dataset we were unable to obtain information on the severity of dementia or risk factors such as lifestyle variables, as well as background information such as socio-economic status.

The selection criteria for the study subjects were specific to ensure only patients with late-onset dementia were included; however it was not possible to differentiate between dementia subtypes. To reduce the chance of risk factor variables not being identified in the premorbid time frame, the cases had to have at least 3 years registration prior to the date of dementia diagnosis and had to have consulted in the year preceding the dementia diagnosis, as did the matched controls. A total of 662 people with a dementia code had to be excluded from the cohort as they lacked 3 years continuous registration prior to their diagnosis. This loss of potential cases decreased the sample size but increased the internal validity of the study as only people with a theoretically ‘new’ diagnosis of dementia were included. The majority of these 662 would likely have a prior history of dementia. This patient movement is likely to represent the migratory nature of patients with dementia and reflect the findings of Rait et al. where more than twice the number of people with dementia than without dementia moved between practices.39 It is possible that the study could have excluded patients with the more severe and advanced cases of dementia (i.e. those not able to function in their own homes and needing to move into residential or nursing care) and hence not be entirely representative of the true community sample of people with dementia.

This study also only looked at co-morbidities in the recent past (up to 8 years) before dementia was diagnosed, meaning it could not look at long-term effects of disease. It was also not possible to analyse all recognised risk factors due to lack of Read coded data found in primary care records, such as Apolipoprotein E4 status. Furthermore even though this study used at least a 3-year exposure timescale before diagnosis, we cannot be completely certain of the temporal relationship between exposure and disease outcome using a case-control design because of the insidious and latent aspects of dementia.22 Further prospective studies are needed to investigate the influence of prior depression and anxiety as a cause for dementia. The findings presented are based on the frequency matching of cases and controls rather than perfect matching for two reasons. First, the frequency matching selection increased the power and efficiency of the study. Second, previous studies40,41 found that unconditional logistic regression with adjustments of match variables can derive similar estimates with the conditional logistic regression where perfect matching of cases and controls were required.

Conclusions

This study supports observations that anxiety independently increases the likelihood of later being diagnosed with dementia. In order to support current national guidelines and strategies to improve the rate of earlier diagnosis of dementia and hence access to holistic management, clinicians should be vigilant to symptoms of cognitive impairment especially in older patients with a past history of anxiety, depression and cerebrovascular disease.

Declaration

Funding: CLB’s academic extension was funded by the West Midlands Deanery. CiPCA was funded by the North Staffordshire Primary Care Research Consortium and the National Coordinating Centre for Research Capacity Development. Christian Mallen is funded by an Arthritis Research UK Clinician Scientist Award.

Ethical approval: Use of the CiPCA database for anonymised patient research was granted by the North Staffordshire Research Ethics Committee.

Conflict of interest: none.

Acknowledgements

The authors would like to thank The Keele GP Research Partnership and the Informatics team at the Arthritis Research UK Primary Care Centre.

References

  • 1. Knapp M, Prince M, Albanese E, et al. Dementia UK: The Full Report http://www.alzheimers.org.uk/downloads/Dementia_UK_Full_Report.pdf 2007. London, Alzheimer’s Society; (accessed on 14 August 2009). [Google Scholar]
  • 2. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M. Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 2007; 22(10): 1037–45 [DOI] [PubMed] [Google Scholar]
  • 3. Department of Health Living Well with Dementia: A National Dementia Strategy. Published on 3 February 2009 [Google Scholar]
  • 4. National Audit Office Improving Services and Support for People with Dementia London: The Stationery Office, 2007, p.7 [Google Scholar]
  • 5. Patterson P, Feightner J, Garcia A, MacKnight C. General risk factors for dementia: a systematic evidence review. Alzheimers Dement 2007; 3: 341–47 [DOI] [PubMed] [Google Scholar]
  • 6. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000; 46(4): 219–27 [DOI] [PubMed] [Google Scholar]
  • 7. Martinez F, Flores C, de las Heras P. et al. Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain). BMC Neurol 2008; 8: 39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Ritchie K, Ritchie C, Berr C, Artero S, Ancelin M-L. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 2010; 341: 3885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Fuhrer R, Cufouil C, Dartigues J. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID study. J Am Geriatr Soc 2003; 51(1055): 1063 [DOI] [PubMed] [Google Scholar]
  • 10. Herbert R, Linsay J, Verreault R, et al. Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 2000; 31: 1487–93 [DOI] [PubMed] [Google Scholar]
  • 11. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(1): 8–19 [DOI] [PubMed] [Google Scholar]
  • 12. Wittchen H, Kessler R, Pfister H, Höfler M, Lieb R. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl 2000; 406: 14–23 [PubMed] [Google Scholar]
  • 13. Gallacher J, Bayer A, Fish M, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 2009; 71: 659–66 [DOI] [PubMed] [Google Scholar]
  • 14. Jordan K, Porcheret M, Croft P. Quality of morbidity coding in general practice computerized medical records: a systematic review. Fam Pract 2004; 21: 396–412 [DOI] [PubMed] [Google Scholar]
  • 15. Thomas I. Arthritis Research UK Primary Care Centre, Keele University. The CiPCA Database: Powerpoint Presentation 2009. (accessed on 3 September 2009). [Google Scholar]
  • 16. NHS Connecting for Health Frequently Asked Question about Clinical Terms (The Read Codes)http://www.connectingforhealth.nhs.uk/systemsandservices/data/uktc/readcodes/index_htmldated 2012 (accessed on 27 August 2010)
  • 17. Harwood D, Kalechstein A, Warren W, et al. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease. Int J Geriatr Psychiatry 2010; 25(5): 511–8 [DOI] [PubMed] [Google Scholar]
  • 18. Larrieu S, Letenneur L, Helmer C, Dartigues J, Barberger-Gateau P. Nutritional factors and the risk of incident dementia in the PAQUID longitudinal cohort. J Hum Nutr Diet 2004; 8: 150–4 [PubMed] [Google Scholar]
  • 19. Luchsinger J, Tang M-X, Siddiqui M, She S, Mayeux R. Alcohol intake and the risk of dementia. J Am Geriatr Soc 2004; 52(4): 540–6 [DOI] [PubMed] [Google Scholar]
  • 20. Almeida OP, Hulse GK, Lawrence D, Flicker L. Smoking as a risk factor for Alzheimer’s disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2002; 97(1): 15–28 [DOI] [PubMed] [Google Scholar]
  • 21. Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9(3): 204–18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kivipelto M, Ngandu T, Laatikainen T, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5: 735–41 [DOI] [PubMed] [Google Scholar]
  • 23. Birkenhager WH, Staessen JA. Blood pressure and dementia. Panminerva Med 2004; 46(4): 227–37 [PubMed] [Google Scholar]
  • 24. Honig L, Tang M-X, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707–12 [DOI] [PubMed] [Google Scholar]
  • 25. Ivan C, Seshadri S, Beiser A, et al. Dementia after stroke: the Framingham Study. Stroke 2004; 35: 1264–68 [DOI] [PubMed] [Google Scholar]
  • 26. Guo C, Viitanen M, Winland B, Fratigloni L. Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc 1999; 47: 723–6 [DOI] [PubMed] [Google Scholar]
  • 27. Anstey KJ, Lipnicki DM, Low L-F. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008; 16(5): 343–54 [DOI] [PubMed] [Google Scholar]
  • 28. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5(1): 64–74 [DOI] [PubMed] [Google Scholar]
  • 29. Kloppenborg RP, Van den BE, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008; 585(1): 97–108 [DOI] [PubMed] [Google Scholar]
  • 30. Yaffe K, Blackwell T, Kanaya AM, et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63(4): 658–63 [DOI] [PubMed] [Google Scholar]
  • 31. Palmer K, Berger AK, Monastero R, et al. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68(19): 1596–602 [DOI] [PubMed] [Google Scholar]
  • 32. Bierman EJM, Comijs HC, Rijman F, Jonker C, Beekman A. Anxiety symptoms and cognitive performance in later life: Results from the longitudinal aging study. Aging Ment Health 2008; 12(4): 517–23 [DOI] [PubMed] [Google Scholar]
  • 33. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925–35 [DOI] [PubMed] [Google Scholar]
  • 34. Cherubini A, Lowenthal D, Paran E, et al. Hypertension and cognitive function in the elderly. Dis Mon 2010; 56(3): 106–47 [DOI] [PubMed] [Google Scholar]
  • 35. Li G, Higdon R, Kukull WA, et al. Statin therapy and risk of dementia in the elderly: a community-based cohort study. Neurology 2004; 63: 1624–8 [DOI] [PubMed] [Google Scholar]
  • 36. Li N-C, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 2010; 340: b5465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum Lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59(3): 492–4 [DOI] [PubMed] [Google Scholar]
  • 38. Zandi PP, Sparks L, Khachaturian Z, et al. Do statins reduce risk of incident dementia in Alzheimer disease? Arch Gen Psychiatry 2005; 62: 217–24 [DOI] [PubMed] [Google Scholar]
  • 39. Rait G, Walters K, Bottomley C, et al. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ 2010; 341: 3584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Stürmer T, Brenner H. Degree of matching and gain in power and efficiency in case-control studies. Epidemiology 2001; 12(1): 101–8 [DOI] [PubMed] [Google Scholar]
  • 41. Yusuf S, Hawken S, Öunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52 [DOI] [PubMed] [Google Scholar]

Articles from Family Practice are provided here courtesy of Oxford University Press

RESOURCES